Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-30 @ 12:27 AM
Study NCT ID:
NCT01176968
Status:
COMPLETED
Last Update Posted:
2020-12-22
First Post:
2010-08-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-04
First Submit QC Date:
None
Study First Post Date:
2010-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-10-18
Results First Submit QC Date:
None
Results First Post Date:
2016-08-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-19
Last Update Post Date:
2020-12-22
Last Update Post Date Type:
ACTUAL